Tag - moderna

 
 

MODERNA

Japan Times
BUSINESS
Jul 6, 2023
Moderna signs deal with Shanghai to make mRNA vaccines for Chinese market
The Massachusetts-based company will work with local government to conduct clinical trials and apply to bring products to market as well as to produce them in China.
Japan Times
WORLD / Science & Health
Jun 6, 2023
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck-Moderna data
Scientists have been chasing the dream of vaccines to treat cancer for decades with few successes.
Japan Times
COMMENTARY / World
Apr 21, 2023
Cancer vaccine hunt makes progress, finally
A small cancer drug study shows promise in deploying mRNA technology against melanoma, but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
WORLD / Science & Health
Apr 17, 2023
Moderna-Merck cancer vaccine plus Keytruda delays recurrence of skin cancer
The findings of the recent trial suggest that adding a personalized cancer vaccine to antibody-based immunotherapy could prolong the time patients have without death or the cancer"s return.
Japan Times
COMMENTARY / World
Jan 4, 2023
Cancer vaccine hunt finally makes progress
A small study shows promise in deploying mRNA technology against melanoma u2014 but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
JAPAN
Sep 12, 2022
Japan health ministry backs Pfizer and Moderna omicron boosters
Pfizeru2019s omicron booster can be administered to people age 12 and over, while Modernau2019s is limited to those 18 and above, the panel advised.
Japan Times
JAPAN / Science & Health / EXPLAINER
Aug 12, 2022
What we know about the new omicron vaccines
New vaccines developed for the COVID-19 omicron variant are scheduled to be available from mid-October in Japan, raising hopes that the population will soon be better protected.
Japan Times
JAPAN
Aug 10, 2022
Shionogi confirms efficacy of oral COVID drug for omicron subvariant
The announcement came after a health ministry panel in July postponed the granting of emergency approval for the drug.
Japan Times
JAPAN
Jun 3, 2022
Skin rash more common in women after Moderna shot, Japan study finds
Swelling, pain and/or itchiness of the arm that received the vaccine was also more common among people in their 30s through 60s.
Japan Times
COMMENTARY / World
Apr 11, 2022
We need better COVID-19 booster shots, not more of the same
There are 100 new Covid vaccines in development. One of them could offer better protection against omicron.
Japan Times
BUSINESS / Companies
Mar 23, 2022
With sumo flag sponsorship deal, COVID vaccine-maker Moderna reveals Japan ambition
The U.S. firm is seeking to build on its newfound renown in COVID-19 vaccines and wrestle market share from compatriot Pfizer Inc.
Japan Times
JAPAN
Feb 7, 2022
Japan's booster rollout is relying on Pfizer and Moderna. How do the shots compare?
Despite an apparent preference among some in the general public for Pfizer, experts have emphasized that getting a booster jab as soon as one is eligible, no matter which type, is key.
Japan Times
WORLD
Jan 27, 2022
Moderna starts trial for omicron-specific booster shot
The news comes a day after rival vaccine developer Pfizer Inc. launched a similar trial.
Japan Times
WORLD / Science & Health
Jan 16, 2022
The decades of discoveries before the ‘miraculous’ sprint to a vaccine
The breakthroughs behind the vaccines unfolded over decades, little by little, as scientists across the world pursued research in disparate areas.
Japan Times
WORLD / Science & Health
Jan 11, 2022
Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate
While there were some caveats, the findings will likely add to concerns around the efficacy of Sinovacu2019s and Sinopharm Groupu2019s shots, which have been widely used in the developing world.
Japan Times
JAPAN / Explainer
Jan 6, 2022
The ins and outs of Japan's COVID-19 booster shot rollout
Japan recommends people receive a different shot for their third doses to the one they received in the initial rollout, but what's the rationale behind that strategy?
Japan Times
WORLD / Science & Health
Dec 20, 2021
Moderna says its booster dose appears protective against omicron
The data, which has not yet been peer reviewed, tested blood from people who had received the vaccine against a pseudovirus engineered to resemble the omicron variant.
Japan Times
BUSINESS
Dec 14, 2021
Moderna to produce millions of mRNA vaccines in Australia
The deal underscores efforts by governments around the world to build up local production and prepare for future pandemic threats.
Japan Times
COMMENTARY / World
Dec 1, 2021
What’s worst about omicron so far is the uncertainty
How should the world respond to omicron? We just have to wait as there is information that we donu2019t yet have. And for many, the waiting itself is the problem.
Japan Times
WORLD / Science & Health
Nov 28, 2021
Moderna says new vaccine for omicron may be ready in early 2022
Moderna's chief medical officer says the company should know about the ability of the current vaccine to provide protection in the next couple of weeks.

Longform

Hideo Shimoju points to a possible site that his fellow neighbors may relocate to. Such relocations have happened before, but not preemptively.
In disaster-prone Japan, some communities consider major moves